The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN

Olvert A. Berkhemer, Lucie A. van den Berg, Puck S. S. Fransen, Debbie Beumer, Albert J. Yoo, Hester F. Lingsma, Wouter J. Schonewille, Rene van den Berg, Marieke J. H. Wermer, Jelis Boiten, Geert J. Lycklama Nijeholt, Paul J. Nederkoorn, Markus W. Hollmann, Wim H. van Zwam, Aad van der Lugt, Robert J. van Oostenbrugge, Charles B. L. M. Majoie, Diederik W. J. Dippel, Yvo B. W. E. M. Roos*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Background: The aim of the current study was to assess the influence of anesthetic management on the effect of treatment in the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN). Methods: MR CLEAN was amulticenter, randomized, open-label trial of intra-arterial therapy (IAT) vs no IAT. The intended anesthetic management at the start of the procedure was used for this post hoc analysis. The primary effect parameter was the adjusted common odds ratio (acOR) for a shift in direction of a better outcome on the modified Rankin Scale (mRS) at 90 days, estimated with multivariable ordinal logistic regression analysis, which included a term for general anesthesia (GA). Results: GA was associated with significant (p=0.011) effect modification, resulting in estimated decrease of 51%(95% confidence interval [CI] 31%-86%) in treatment effect compared to non-GA. We found a shift in the distribution on the mRS in favor of non-GA compared to control group (acOR 2.18 [95% CI 1.49-3.20]). The shift in distribution between GA and control group was in a similar direction (acOR 1.12 [95% CI 0.71-1.78]) with loss of statistical significance. Conclusions: In this post hoc analysis, we found that the type of anesthetic management influences outcome following IAT. Only treatment without general anesthesia was associated with a significant treatment benefit in MR CLEAN. Classification of evidence: This study provides Class II evidence that for patients with acute ischemic stroke undergoing IAT, mRS scores at 90 days improve only in patients treated without GA.
Original languageEnglish
Pages (from-to)656-664
Issue number7
Publication statusPublished - 16 Aug 2016

Cite this